Indication
Bullous Keratopathy
1 clinical trial
1 product
Product
EO2002Clinical trial
A Phase 1, Prospective, Multi-Center, Open-Label, Dose-Escalation Study to Assess the Safety, and Tolerability of EO2002 With and Without Endothelial Brushing or Descemet Stripping in the Treatment of Corneal Edema (EMME-001)Status: Active (not recruiting), Estimated PCD: 2024-10-30